Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Paul Macri

Paul Macri

ID: 1b83b924-2619-30fb-68c4

/

Claimed Record

/

Organization: Rothwell Figg

BPCIA Litigation Update: Amgen v. Sandoz in the District of New Jersey

Biosimilars Law Bulletin · June 22, 2023

Recent FDA Discussion of Artificial Intelligence for Biosimilar Industry

Biosimilars Law Bulletin · April 25, 2023

Legislative Efforts to Remove Impediments to Biosimilar Approvals and Marketing

Biosimilars Law Bulletin · March 1, 2023

Declaratory Judgment Jurisdiction Over Skinny Label Applications: <i>In re: Entresto</i> (Sacubitril/Valsartan) Patent Litigation

Biosimilars Law Bulletin · October 25, 2022

Practice Areas

Health Care and Life Sciences

Jurisdictions

Washington, D.C.

Publishing Record

Publisher Since 2022

Total Articles 4

Most Recent June 22, 2023

Cite This Author

Paul Macri, Rothwell Figg

LexBlog Author ID:

1b83b924-2619-30fb-68c4

www.lexblog.com/author/pmacri

Contact

FirmRothwell Figg

Emailpmacri@rothwellfigg.com

BlogBiosimilars Law Bulletin

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog